Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2021

Fair Value Measurements

Schedule of Company's assets that are measured at fair value on a recurring basis

	Fair Value Measured as of March 31, 2021
	Level 1		Level 2		Level 3		Total
Assets:
Investments held in Trust Account	$	414,080,084	$	—	$	—	$	414,080,084
Liabilities:
Derivative liabilities - public warrants	$	12,144,000	$	—	$	—	$	12,144,000
Derivative liabilities - private placement warrants	$	—	$	6,500,270	$	—	$	6,500,270
Derivative liabilities - forward purchase agreement	$	—	$	—	$	757,830	$	757,830
Total liabilities	$	12,144,000	$	6,500,270	$	757,830	$	19,402,100

	Fair Value Measured as of December 31, 2020
	Level 1		Level 2		Level 3		Total
Assets:
Investments held in Trust Account	$	414,020,525	$	—	$	—	$	414,020,525
Liabilities:
Derivative liabilities - public warrants	$	—	$	—	$	21,390,000	$	21,390,000
Derivative liabilities - private placement warrants	$	—	$	—	$	11,449,330	$	11,449,330
Derivative liabilities - forward purchase agreement	$	—	$	—	$	7,692,950	$	7,692,950
Total liabilities	$	—	$	—	$	40,532,280	$	40,532,280

Schedule of change in the fair value of the derivative liabilities

Beginning of period
Warrant liabilities – Public		21,390,000
Warrant liabilities – Private		11,449,330
Forward purchase agreement		7,692,950
Beginning of period total	$	40,532,280
Change in fair value of warrant liabilities – Public		(9,246,000)
Change in fair value of warrant liabilities – Private		(4,949,060)
Change in fair value of forward purchase agreement		(6,935,120)
End of period	$	19,402,100

Level 3 derivative liabilities at December 31, 2020	$	40,532,280
Transfers out of Level 3		(32,839,330)
Change in fair value		(6,935,120)
Level 3 derivative liabilities at March 31, 2021	$	757,830

Schedule of quantitative information regarding Level 3 fair value measurements inputs

	As of			As of
	March 31, 2021			December 31, 2020
Share price, used in warrant valuations		n/a		$	10.02
Unit price, used in forward valuation	$	10.05		$	10.54
Exercise price, warrants		n/a		$	11.50
Exercise price, forward	$	10.00		$	10.00
Term (in years), used in warrant valuations		n/a			6.00
Term (in years), used in forward valuation		0.71			0.96
Volatility		n/a			21.00	%
Risk-free interest rate, used in warrant valuations		n/a			0.50	%
Risk-free interest rate, used in forward valuation		0.06	%		0.10	%
Expected dividends		n/a			n/a